Search results

ANSTO renewed its Memorandum of Understanding (MOU) with the Japan Proton Accelerator Research Complex (J-PARC) operated by the High Energy Accelerator Research Organisation (KEK) and Japan Atomic Energy Agency (JAEA). Now broadened to include their partner Comprehensive Research Organization for Science and Society (CROSS), the signing took place early in the year and a celebratory workshop was held late July.

Research has demonstrated that internally generated neutrons could be used to effectively target micro-infiltrates and cancer cells outside of the defined treatment regions.

Phase contrast tomography shows great promise in early stages of study and is expected to be tested on first patients by 2020.

Dr Richard Garrett featured on an ABC National program that highlighted how far we are from a future with nuclear fusion energy. Image: Jamison Daniel, Oak Ridge Leadership Computing Facility

ANSTO’s nuclear medicine processing and distribution facility assembles, loads, tests and distributes a range of nuclear medicine products, including Mo-99. The Mo-99 is dispensed into an ANSTO radiopharmaceutical Gentech® Generator where it decays to Tc-99m.

Radioisotopes are widely used in medicine, industry, and scientific research. New applications for radioisotopes are constantly being developed.

ANSTO has made two public submissions to parliamentary inquiries with another to be submitted in February 2020 on matters relating to nuclear technologies, their peaceful applications, and the nuclear fuel cycle.

ANSTO expert in molecular imaging contributed to international workshop.

Congress marks watershed moment for nuclear medicine and ANSTO

Environmental Scientist Amy Macintosh is researching the impact of the petroleum industry on Australian marine life.

ANSTO will be participating in a new Industrial Transformation Training Centre established and funded by the Australia Research Council to advance the use of bioactive ingredients in Australia.

ANSTO continues a longstanding, mutually-beneficial research relationship with the University of Wollongong following the signing of a strategic agreement this week.

ANSTO is seeking nominations for the ANSTO Australian Synchrotron Stephen Wilkins Thesis Medal.

ANSTO is seeking nominations for the ANSTO Australian Synchrotron Stephen Wilkins Thesis Medal.

With a well-established portfolio of nuclear research and the operation of Australia's only nuclear reactor OPAL, ANSTO scientists conduct both fundamental and applied research on fuel for current, advanced, and future nuclear technology systems.